Kendra A. Young

9.0k total citations
63 papers, 1.7k citations indexed

About

Kendra A. Young is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Rheumatology. According to data from OpenAlex, Kendra A. Young has authored 63 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 14 papers in Immunology and 11 papers in Rheumatology. Recurrent topics in Kendra A. Young's work include Chronic Obstructive Pulmonary Disease (COPD) Research (20 papers), Complement system in diseases (10 papers) and Respiratory Support and Mechanisms (9 papers). Kendra A. Young is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (20 papers), Complement system in diseases (10 papers) and Respiratory Support and Mechanisms (9 papers). Kendra A. Young collaborates with scholars based in United States, United Kingdom and Japan. Kendra A. Young's co-authors include V. Michael Holers, Jill M. Norris, Joel M. Guthridge, Xiaojiang S. Chen, Gerda Szakonyi, Carl D. Langefeld, Jonathan P. Hannan, Paul A. Trainor, Linda J. Sandell and Gennadiy Moiseyev and has published in prestigious journals such as Science, Journal of Biological Chemistry and Circulation.

In The Last Decade

Kendra A. Young

57 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kendra A. Young United States	23	488	385	302	298	248	63	1.7k
Kathleen Haines United States	26	664 1.4×	502 1.3×	170 0.6×	250 0.8×	498 2.0×	44	2.0k
Nils Venhoff Germany	24	394 0.8×	319 0.8×	495 1.6×	181 0.6×	506 2.0×	111	2.1k
António Marinho Portugal	22	429 0.9×	228 0.6×	152 0.5×	195 0.7×	357 1.4×	92	1.3k
Tim Ulinski France	25	408 0.8×	426 1.1×	262 0.9×	165 0.6×	195 0.8×	93	1.9k
José Luís Callejas-Rubio Spain	27	722 1.5×	206 0.5×	426 1.4×	398 1.3×	1.0k 4.1×	143	2.2k
Anish Mehta India	21	806 1.7×	200 0.5×	210 0.7×	216 0.7×	183 0.7×	103	1.9k
Masayuki Endoh Japan	25	367 0.8×	436 1.1×	184 0.6×	201 0.7×	159 0.6×	122	2.0k
Steven E. Carsons United States	27	908 1.9×	486 1.3×	156 0.5×	144 0.5×	593 2.4×	92	2.6k
Hubert Nivet France	28	890 1.8×	581 1.5×	623 2.1×	244 0.8×	117 0.5×	99	3.1k

Countries citing papers authored by Kendra A. Young

Since Specialization

Citations

This map shows the geographic impact of Kendra A. Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kendra A. Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kendra A. Young more than expected).

Fields of papers citing papers by Kendra A. Young

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kendra A. Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kendra A. Young. The network helps show where Kendra A. Young may publish in the future.

Co-authorship network of co-authors of Kendra A. Young

This figure shows the co-authorship network connecting the top 25 collaborators of Kendra A. Young. A scholar is included among the top collaborators of Kendra A. Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kendra A. Young. Kendra A. Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Young, Kendra A., et al.. (2025). Outcomes of Grade 3 Carotid Dissections: A 7-Year Retrospective Analysis of Stroke, Stenosis, and Pseudoaneurysm Progression. Journal of Stroke and Cerebrovascular Diseases. 34(7). 108307–108307.

Kinney, Gregory L., et al.. (2025). The Correlational Structure of Lung CT and PFT in COPD Are Stable Over Five Years. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A1241–A1241.

Munroe, Melissa E., Kendra A. Young, Rufei Lu, et al.. (2025). Dysregulated soluble immune mediators and lupus-associated autoantibody specificities inform the development of immune indexes that characterise classified SLE transition and SLE disease activity. Lupus Science & Medicine. 12(2). e001753–e001753. 1 indexed citations

Young, Kendra A., et al.. (2025). West Nile Virus Encephalitis in a Lung Transplant Recipient. The Journal of Heart and Lung Transplantation. 44(4). S310–S311.

Yang, Han‐Mo, Min Hyung Ryu, Vincent J. Carey, et al.. (2024). Differential Association of COPD Subtypes With Cardiovascular Events and COPD Exacerbations. CHEST Journal. 166(6). 1360–1370. 5 indexed citations

Díaz, Alejandro A., Wei Wang, W.R. Dolliver, et al.. (2023). Suspected Bronchiectasis and Mortality in Adults With a History of Smoking Who Have Normal and Impaired Lung Function. Annals of Internal Medicine. 176(10). 1340–1348. 4 indexed citations

Non, Amy L., Barbara Bailey, Surya P. Bhatt, et al.. (2023). Race-Specific Spirometry Equations Do Not Improve Models of Dyspnea and Quantitative Chest CT Phenotypes. CHEST Journal. 164(6). 1492–1504. 12 indexed citations

Dolliver, W.R., Wei Wang, Pietro Nardelli, et al.. (2022). Pulmonary arterial pruning is associated with CT-derived bronchiectasis progression in smokers. Respiratory Medicine. 202. 106971–106971. 1 indexed citations

Dai, Ran, Yeongjin Gwon, Stephen I. Rennard, et al.. (2022). Identifying Individual Medications Affecting Pulmonary Outcomes When Multiple Medications are Present. Clinical Epidemiology. Volume 14. 731–735.

10.

Díaz, Alejandro A., Pietro Nardelli, Wei Wang, et al.. (2022). Artificial Intelligence–based CT Assessment of Bronchiectasis: The COPDGene Study. Radiology. 307(1). e221109–e221109. 21 indexed citations

11.

Wan, Emily S., Craig P. Hersh, A. Schwartz, et al.. (2021). Inhaled Medication Use in Smokers With Normal Spirometry. Respiratory Care. 66(4). 652–660. 1 indexed citations

12.

Ragland, M.F., Matthew Strand, David Baraghoshi, et al.. (2021). 10-Year Follow-Up of Lung Function, Respiratory Symptoms, and Functional Capacity in the COPDGene Study. Annals of the American Thoracic Society. 19(3). 381–388. 8 indexed citations

13.

Ragland, M.F., Erin Austin, Kendra A. Young, et al.. (2020). <p>Co-Morbidity Patterns Identified Using Latent Class Analysis of Medications Predict All-Cause Mortality Independent of Other Known Risk Factors: The COPDGene<sup>®</sup> Study</p>. Clinical Epidemiology. Volume 12. 1171–1181. 4 indexed citations

14.

Jog, Neelakshi R., Kendra A. Young, Melissa E. Munroe, et al.. (2019). Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals. Annals of the Rheumatic Diseases. 78(9). 1235–1241. 71 indexed citations

15.

Young, Kendra A., Elizabeth A. Regan, MeiLan K. Han, et al.. (2019). Subtypes of COPD Have Unique Distributions and Differential Risk of Mortality. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 6(5). 400–413. 32 indexed citations

16.

Lee, C. Christine, Kendra A. Young, Jill M. Norris, et al.. (2017). Association of Directly Measured Plasma Free 25(OH)D With Insulin Sensitivity and Secretion: The IRAS Family Study. The Journal of Clinical Endocrinology & Metabolism. 102(8). 2781–2788. 12 indexed citations

17.

Gan, Ryan W., Kendra A. Young, Gary O. Zerbe, et al.. (2015). Lower omega-3 fatty acids are associated with the presence of anti-cyclic citrullinated peptide autoantibodies in a population at risk for future rheumatoid arthritis: a nested case-control study. Lara D. Veeken. 55(2). 367–376. 59 indexed citations

18.

Asokan, Rengasamy, Jing Hua, Kendra A. Young, et al.. (2006). Characterization of Human Complement Receptor Type 2 (CR2/CD21) as a Receptor for IFN-α: A Potential Role in Systemic Lupus Erythematosus. The Journal of Immunology. 177(1). 383–394. 61 indexed citations

19.

Hannan, Jonathan P., Kendra A. Young, Joel M. Guthridge, et al.. (2004). Mutational Analysis of the Complement Receptor Type 2 (CR2/CD21)–C3d Interaction Reveals a Putative Charged SCR1 Binding Site for C3d. Journal of Molecular Biology. 346(3). 845–858. 44 indexed citations

20.

Guthridge, Joel M., Kendra A. Young, Matthew G. Gipson, et al.. (2001). Epitope Mapping Using the X-Ray Crystallographic Structure of Complement Receptor Type 2 (CR2)/CD21: Identification of a Highly Inhibitory Monoclonal Antibody That Directly Recognizes the CR2-C3d Interface. The Journal of Immunology. 167(10). 5758–5766. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact